Search

Your search keyword '"TEST systems"' showing total 171,410 results

Search Constraints

Start Over You searched for: "TEST systems" Remove constraint "TEST systems"
171,410 results on '"TEST systems"'

Search Results

3. Aehr Test Systems secures first multisystem orders for Sonoma system

4. Aehr Test Systems completes acquisition of Incal Technology

6. Aehr Test Systems receives $12.7M in orders for WaferPak full wafer contactors

7. Aehr Test Systems to acquire Incal for $21M in cash and stock, sees accretion

8. Aehr Test Systems options imply 11.4% move in share price post-earnings

9. Aehr Test Systems jumps 15% to $14.25 after raising FY24 revenue guidance

10. Aehr Test Systems sees Q4 revenue $16.6M, consensus $15.45M

11. Aehr Test Systems reports Q4 EPS 84c, consensus 10c

14. Aehr Test Systems options imply 6.3% move in share price post-earnings

17. Performance evaluation of cefoxitin screen test on two different automated antimicrobial susceptibility test systems: a comparative study

18. Simplified Method for Removing Direct Oral Anticoagulant Interference in Mechanical Coagulation Test Systems—A Proof of Concept.

19. Q3 2024 Aehr Test Systems Earnings Call - Final

20. Testing of diagnostic test-systems for detection of antibodies to foot-and-mouth disease virus structural proteins with enzyme-linked immunosorbent assay for their serotype specificity

21. A set of Non-Synthetic test systems of European LV Rural, LV urban and hybrid MV/LV industrial distribution networks

24. Aehr Test Systems downgraded at William Blair after Q3 miss, FY24 guidance cut

26. Aehr Test Systems falls 21% to $11.53 after Q3 preannouncement, guidance cut

27. Aehr Test Systems sees 2024 adjusted EPS at least 48c

28. FORM 8-K: AEHR TEST SYSTEMS Files Current Report (Sep 06, 2024)

30. FORM 8-K: AEHR TEST SYSTEMS Files Current Report (Aug 01, 2024)

31. FORM 8-K: AEHR TEST SYSTEMS Files Current Report (Jul 09, 2024)

33. Aehr Test Systems sees Q3 adjusted EPS (3c)-(4c)

34. Researcher from bioMerieux Reports Recent Findings in Microbiology (Performance evaluation of cefoxitin screen test on two different automated antimicrobial susceptibility test systems: a comparative study)

35. Aehr Test Systems sees FY25 revenue at least $70M, consensus $67.86M

36. Aehr Test Systems sees FY24 revenue $66.2M, consensus $65.11M

37. 8-K: AEHR TEST SYSTEMS

38. STANDARDIZATION OF THE PROTEIN CALIBRATORS ISOLATION METHODOLOGY FOR THROMBOPHILIA MARKERS DETECTING IMMUNODIAGNOSTIC TEST SYSTEMS

39. Adolescents’ Cognitive Abilities, Reaction Time, and Working Memory Performance by Vienna Test Systems.

41. Cytogenetic Studies on Genoprotective Effect of Rosa damascena Mill. Hydrosol in Plant and Lymphocyte Test Systems.

43. Classification of “Near-patient” and “Point-of-Care” SARS-CoV-2 Nucleic Acid Amplification Test Systems and a first approach to evaluate their analytical independence of operator activities

45. Aehr Test Systems selloff brings buying opportunity, says William Blair

46. Aehr Test Systems call volume above normal and directionally bullish

47. Aehr Test Systems options imply 12.7% move in share price post-earnings

49. Performance evaluation of cefoxitin screen test on two different automated antimicrobial susceptibility test systems: a comparative study.

50. Aehr Test Systems participates in a conference call with William Blair

Catalog

Books, media, physical & digital resources